Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|January 1, 2010
Identification and functional characterization of the first nucleobase transporter in mammals: implication in the species difference in the intestinal absorption mechanism of nucleobases and their analogs between higher primates and other mammalsSyunsuke Yamamoto, Katsuhisa Inoue, Tomoaki Murata, et al.
Pharmaceutical Research|April 3, 2019
Direct Drug Delivery of Low-Permeable Compounds to the Central Nervous System Via Intranasal Administration in Rats and MonkeysShinji Iwasaki, Syunsuke Yamamoto, Noriyasu Sano, et al.
Plos One|May 7, 2025
AAV delivery of GBA1 suppresses α-synuclein accumulation in Parkinson's disease models and restores functions in Gaucher's disease modelsTakuro Okai, Sho Sato, Mugdha Deshpande, et al.
Materials Today. Bio|March 21, 2022
Brain microvascular endothelial cells derived from human induced pluripotent stem cells as in vitro model for assessing blood-brain barrier transferrin receptor-mediated transcytosisMarie Piantino, Fiona Louis, Yukari Shigemoto-Mogami, et al.
Current Radiopharmaceuticals|December 31, 2016
Development of a Novel Carbon-11 Labeled PET Radioligand for Melanin- Concentrating Hormone Receptor 1Hideyuki Igawa, Vladimir Stepanov, Lenke Tari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2023
Preferential delivery of lipid-ligand conjugated DNA/RNA heteroduplex oligonucleotide to ischemic brain in hyperacute stageFuying Li, Keiko Ichinose, Satoru Ishibashi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 13, 2025
Pharmacokinetics and protein binding of cholesterol-conjugated heteroduplex oligonucleotideYukitake Yoshioka, Syunsuke Yamamoto, Kosuke Kusamori, et al.
European Journal of Pharmacology|July 24, 2017
A pyridone derivative activates SERCA2a by attenuating the inhibitory effect of phospholambanManami Kaneko, Hisato Yamamoto, Hiroki Sakai, et al.
Molecular Therapy. Methods & Clinical Development|October 13, 2025
Biodistribution of AAV1, AAV5, AAV9, and AAVDJ serotypes after intra-cisterna magna delivery in non-human primatesTakuro Okai, Sho Sato, Hironobu Yasuno, et al.
European Journal of Pharmacology|December 18, 2016
A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent modelsYayoi Kawata, Shoki Okuda, Natsu Hotta, et al.
Pageof 5